로딩 중…
지수 로딩 중…
Biohaven Ltd.
BHVN· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$13.36-1.04%
2026-08-03
Financials
Valuation Metrics
Biohaven Ltd.'s Market Cap is $2.01B. At end of 2025 it was $1.36B. Ranked #2053 of 3,112 in US market (top 66%), #1266 of 1,667 on NYSE (top 76%), #135 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 50%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.01B | US#2,053/3,112 Sec#135/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-648M | US—/3,112 Sec—/269 |
| Total Assets | $466M | US#2,770/3,112 Sec#164/269 |
| Net Assets | $130M | US#2,843/3,112 Sec#216/269 |
| Value | ||
| P/B | 15.53x | US#2,739/3,112 Sec#219/269 |
| FCF Yield | -29.55% | US—/3,112 Sec—/269 |
| Financial Health | ||
| Debt Ratio | 260.16% | US#2,011/3,112 Sec#213/269 |
| Total Debt | $286M | US#2,057/3,112 Sec#78/269 |
| FCF | $-594M | US#2,849/3,112 Sec#263/269 |
| Cash | $273M | US#1,490/3,112 Sec#90/269 |
| Current Ratio | 7.41x | US#319/3,112 Sec#104/269 |
| Performance | ||
| 1Y Return | -9.18% | US#2,342/3,112 Sec#209/269 |
| 1M Return | -16.29% | US#2,859/3,112 Sec#214/269 |
| From 52W High | -28.06% | US#2,085/3,112 Sec#153/269 |
| 1Y MDD | -62.11% | US#2,772/3,112 Sec#220/269 |
| Trading | ||
| Volume | 1,322,245 shares | US#1,233/3,112 Sec#120/269 |
| Trading Value | $18M | US#2,042/3,112 Sec#157/269 |
| Per Share | ||
| EPS | $-6.15 | US—/3,112 Sec—/269 |
| BPS | $0.43 | US#2,688/3,112 Sec#222/269 |